Yueer Gene

China
Yaodian, Shaanxi, China

Company profile

Yueer Gene company profile

Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.

Business identity

Contact email
[email protected]
Phone number
400-999-8036
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2017-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$50M
Last funding
Series B / $50M / 2022-06-02
Last equity funding
Series B / $50M
Investors
8
Lead investors
2

Founders and investors

Lead investors

AstraZenecaPan-Lin Capital

Investors

AstraZenecaBoyuan CapitalHSGPan-Lin CapitalPappas Capital